1. Home
  2. PARR vs MDXG Comparison

PARR vs MDXG Comparison

Compare PARR & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PARR
  • MDXG
  • Stock Information
  • Founded
  • PARR 1984
  • MDXG 2006
  • Country
  • PARR United States
  • MDXG United States
  • Employees
  • PARR N/A
  • MDXG N/A
  • Industry
  • PARR Integrated oil Companies
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • PARR Energy
  • MDXG Health Care
  • Exchange
  • PARR Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • PARR 1.2B
  • MDXG 999.9M
  • IPO Year
  • PARR N/A
  • MDXG N/A
  • Fundamental
  • Price
  • PARR $27.87
  • MDXG $5.81
  • Analyst Decision
  • PARR Buy
  • MDXG Strong Buy
  • Analyst Count
  • PARR 7
  • MDXG 2
  • Target Price
  • PARR $22.96
  • MDXG $12.50
  • AVG Volume (30 Days)
  • PARR 1.4M
  • MDXG 505.5K
  • Earning Date
  • PARR 08-05-2025
  • MDXG 07-30-2025
  • Dividend Yield
  • PARR N/A
  • MDXG N/A
  • EPS Growth
  • PARR N/A
  • MDXG N/A
  • EPS
  • PARR N/A
  • MDXG 0.27
  • Revenue
  • PARR $7,738,658,000.00
  • MDXG $352,375,000.00
  • Revenue This Year
  • PARR N/A
  • MDXG $9.55
  • Revenue Next Year
  • PARR N/A
  • MDXG $11.43
  • P/E Ratio
  • PARR N/A
  • MDXG $21.73
  • Revenue Growth
  • PARR N/A
  • MDXG 5.34
  • 52 Week Low
  • PARR $11.86
  • MDXG $5.47
  • 52 Week High
  • PARR $28.30
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • PARR 83.14
  • MDXG 30.41
  • Support Level
  • PARR $21.01
  • MDXG $5.80
  • Resistance Level
  • PARR $22.00
  • MDXG $6.03
  • Average True Range (ATR)
  • PARR 1.13
  • MDXG 0.19
  • MACD
  • PARR 0.41
  • MDXG -0.05
  • Stochastic Oscillator
  • PARR 94.31
  • MDXG 2.47

About PARR Par Pacific Holdings Inc.

Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: